Hugo W. Tilanus

22.9k total citations · 6 hit papers
255 papers, 14.8k citations indexed

About

Hugo W. Tilanus is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Hugo W. Tilanus has authored 255 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Surgery, 108 papers in Pulmonary and Respiratory Medicine and 47 papers in Hepatology. Recurrent topics in Hugo W. Tilanus's work include Esophageal Cancer Research and Treatment (107 papers), Gastric Cancer Management and Outcomes (67 papers) and Esophageal and GI Pathology (57 papers). Hugo W. Tilanus is often cited by papers focused on Esophageal Cancer Research and Treatment (107 papers), Gastric Cancer Management and Outcomes (67 papers) and Esophageal and GI Pathology (57 papers). Hugo W. Tilanus collaborates with scholars based in Netherlands, United States and United Kingdom. Hugo W. Tilanus's co-authors include J. Jan B. van Lanschot, Herman van Dekken, H. Obertop, Herold J. Metselaar, Bas P. L. Wijnhoven, Wim C.J. Hop, Luc J. W. van der Laan, Peter D. Siersema, Jan B.F. Hulscher and Fiebo J.W. ten Kate and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hugo W. Tilanus

254 papers receiving 14.4k citations

Hit Papers

Extended Transthoracic Resection Compared with Limited Tr... 1995 2026 2005 2015 2002 1999 1995 2004 2007 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo W. Tilanus Netherlands 61 9.4k 8.4k 2.2k 1.7k 1.7k 255 14.8k
Yasuyuki Seto Japan 48 4.8k 0.5× 5.3k 0.6× 2.1k 1.0× 1.6k 0.9× 2.6k 1.5× 422 10.0k
Hiroyuki Okada Japan 46 4.1k 0.4× 3.5k 0.4× 1.7k 0.8× 891 0.5× 2.0k 1.2× 575 8.1k
Haruhiko Fukuda Japan 40 4.5k 0.5× 6.9k 0.8× 941 0.4× 634 0.4× 3.4k 2.0× 225 10.0k
Takayuki Matsumoto Japan 46 3.1k 0.3× 2.6k 0.3× 2.2k 1.0× 886 0.5× 2.1k 1.3× 407 7.8k
Edward A. Levine United States 58 7.2k 0.8× 2.9k 0.3× 412 0.2× 1.1k 0.6× 3.1k 1.9× 367 12.1k
Freddy Penninckx Belgium 52 5.5k 0.6× 1.7k 0.2× 834 0.4× 759 0.4× 3.1k 1.8× 251 10.9k
Martin D. McCarter United States 53 2.3k 0.2× 2.3k 0.3× 1.4k 0.6× 1.5k 0.9× 2.8k 1.7× 230 8.4k
Denis Pezet France 46 4.4k 0.5× 3.5k 0.4× 364 0.2× 1.9k 1.1× 3.5k 2.1× 186 8.8k
John Primrose United Kingdom 56 5.0k 0.5× 3.2k 0.4× 300 0.1× 2.0k 1.2× 7.0k 4.2× 230 12.8k
Bryan M. Clary United States 53 3.5k 0.4× 2.4k 0.3× 323 0.1× 1.3k 0.7× 4.5k 2.7× 165 8.4k

Countries citing papers authored by Hugo W. Tilanus

Since Specialization
Citations

This map shows the geographic impact of Hugo W. Tilanus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo W. Tilanus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo W. Tilanus more than expected).

Fields of papers citing papers by Hugo W. Tilanus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo W. Tilanus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo W. Tilanus. The network helps show where Hugo W. Tilanus may publish in the future.

Co-authorship network of co-authors of Hugo W. Tilanus

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo W. Tilanus. A scholar is included among the top collaborators of Hugo W. Tilanus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo W. Tilanus. Hugo W. Tilanus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mancham, Shanta, Monique M.A. Verstegen, Petra E. de Ruiter, et al.. (2015). Human Graft-Derived Mesenchymal Stromal Cells Potently Suppress Alloreactive T-Cell Responses. Stem Cells and Development. 24(12). 1436–1447. 20 indexed citations
2.
Janmaat, Vincent T., Maikel P. Peppelenbosch, Manon C.W. Spaander, et al.. (2015). Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk. Molecular Medicine. 21(1). 346–354. 14 indexed citations
3.
Fouraschen, Suomi M.G., Qiuwei Pan, Petra E. de Ruiter, et al.. (2012). Secreted Factors of Human Liver-Derived Mesenchymal Stem Cells Promote Liver Regeneration Early After Partial Hepatectomy. Stem Cells and Development. 21(13). 2410–2419. 82 indexed citations
4.
Grotenhuis, Brechtje A., Bas P. L. Wijnhoven, Jan Werner Poley, et al.. (2012). Preoperative Assessment of Tumor Location and Station‐Specific Lymph Node Status in Patients with Adenocarcinoma of the Gastroesophageal Junction. World Journal of Surgery. 37(1). 147–155. 52 indexed citations
5.
Boonstra, Jurjen J., Bas P. L. Wijnhoven, Mark van Heijl, et al.. (2011). Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial. BMC Cancer. 11(1). 181–181. 132 indexed citations
6.
Grotenhuis, Brechtje A., Winand N.M. Dinjens, Petra Sonneveld, et al.. (2010). Barrett's oesophageal adenocarcinoma encompasses tumour‐initiating cells that do not express common cancer stem cell markers. The Journal of Pathology. 221(4). 379–389. 19 indexed citations
7.
Ginneken, Berbke T.J. van, Rita J. G. van den Berg-Emons, Herold J. Metselaar, et al.. (2010). Effects of a rehabilitation programme on daily functioning, participation, health-related quality of life, anxiety and depression in liver transplant recipients. Disability and Rehabilitation. 32(25). 2107–2112. 32 indexed citations
8.
Metselaar, Herold J., Nicole M. van Besouw, Shanta Mancham, et al.. (2009). Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transplantation. 16(1). 12–22. 14 indexed citations
9.
Pan, Qiuwei, Scot D. Henry, Herold J. Metselaar, et al.. (2009). Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing. Journal of Molecular Medicine. 87(7). 713–722. 43 indexed citations
10.
Henry, Scot D., et al.. (2007). University of Wisconsin solution enhances gene therapy vector delivery under hypo- and normo-thermic conditions.. American Journal of Transplantation. 7. 437–437. 1 indexed citations
11.
Vliet, Evelyn P.M. van, Aad van der Lugt, Ernst J. Kuipers, et al.. (2007). Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with esophageal or gastric cardia cancer: a comparative study. Journal of Surgical Oncology. 96(3). 200–206. 19 indexed citations
12.
Tilanus, Hugo W. & Johannes B. Reitsma. (2007). Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus. Annals of Surgery. 52 indexed citations
13.
Metselaar, Herold J., Johannes G. Kusters, Pieter E. Zondervan, et al.. (2005). Strain-specific in vitro cytokine production profiles do not predict rat liver allograft survival. Transplant International. 17(12). 779–86. 2 indexed citations
14.
Reuver, Philip de, Vera Pravica, Wim C.J. Hop, et al.. (2003). Recipient CTLA-4 +49 G/G Genotype Is Associated with Reduced Incidence of Acute Rejection After Liver Transplantation. American Journal of Transplantation. 3(12). 1587–1594. 35 indexed citations
15.
Kwekkeboom, Jaap, Mette A.R. Kuijpers, J. IJzermans, et al.. (2003). Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants. Clinical & Experimental Immunology. 132(2). 345–351. 15 indexed citations
16.
Siersema, Peter D., et al.. (2002). Cure of Barrett's carcinoma by ifosfamide chemotherapy. European Journal of Gastroenterology & Hepatology. 14(11). 1261–1264. 1 indexed citations
17.
Meijer, Catharina, Marinus J. Wiezer, Erik Hack, et al.. (2001). COAGULOPATHY FOLLOWING MAJOR LIVER RESECTION: THE EFFECT OF rBPI21 AND THE ROLE OF DECREASED SYNTHESIS OF REGULATING PROTEINS BY THE LIVER. Shock. 15(4). 261–271. 11 indexed citations
18.
Overhagen, Hans van, et al.. (1996). Percutaneous cholecystostomy for patients with acute cholecystitis and an increased surgical risk. CardioVascular and Interventional Radiology. 19(2). 72–76. 49 indexed citations
19.
Menke‐Pluymers, Marian B. E., A Mulder, Wim C.J. Hop, M. van Blankenstein, & Hugo W. Tilanus. (1994). Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group.. Gut. 35(10). 1348–1351. 53 indexed citations
20.
Meijssen, Maarten A.C., et al.. (1992). Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients.. Gut. 33(2). 155–158. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026